European Pharmaceutical Review

OCTOBER 31, 2022

According to the Intergovernmental Panel on Climate Change (IPCC), emissions must achieve reduction of 43 percent by 2030. Sustainable energy strategies for pharmaceutical manufacturers… The post Biopharma successful in achieving climate-related goals, report finds appeared first on European Pharmaceutical Review.

Pharmaceutical Manufacturing 97

Pharmaceutical Manufacturing 97

Express Pharma

JULY 9, 2024

As per Savills India’s report spanning the present decade (2021-2030), India could generate demand for approximately 96 million sq ft of lifesciences R&D real estate, with market value estimates between $16 billion (Rs 1,200 billion) and $34 billion (Rs 2,550 billion).

Pharmaceutical Manufacturing 100

Pharmaceutical Manufacturing 100

Express Pharma

NOVEMBER 29, 2023

Driven by this momentum, I am confident in reaching the 130 billion mark by 2030, advocating for a consistent 10 per cent growth in both domestic and export markets. Despite challenges in CIS countries, the global reception of Indian pharma remains positive. The domestic market has exhibited impressive growth, exceeding 10 per cent.

Packaging 110

Packaging Pharmaceutical Manufacturing 110

Express Pharma

JUNE 14, 2024

India’s pharmaceutical industry is a global powerhouse. It is already a massive $50 billion market and is projected to grow to $130 billion by 2030. There have been persistent concerns about AMR being aggravated by effluents from pharmaceutical manufacturing plants.

Pharmaceutical Companies 100

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Packaging 100

Quality Matters

APRIL 19, 2024

By 2025, PEPFAR aims to procure 15 million HIV tests from African manufacturers. Similarly, by 2030, it plans to put at least two million patients on first-line antiretroviral (ARV) treatments produced on the continent. But PEPFAR is looking to change how it does business.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Packaging Vaccines 52

Express Pharma

MAY 19, 2024

The COVID-19 pandemic has further elevated the significance of this industry, spotlighting India’s role as a major global player in vaccine production and pharmaceutical R&D. Together, this has led to a surge in real estate demand that is likely to reach approximately 96 million sq ft by 2030 (1).

Vaccines 52

Vaccines Pharmaceutical Manufacturing 52

Express Pharma

NOVEMBER 24, 2023

The expo enjoys support from key industry associations such as Bulk Drug Manufacturing Association (BDMA), Federation of Pharma Entrepreneurs (FOPE), Karnataka Drugs and Pharmaceuticals Manufacturers’ Association (KDPMA), Organisation of Pharmaceutical Producers of India (OPPI), and Pharmaceutical Export Promotion Council (Pharmexcil).

Packaging 98

Packaging Vaccines Pharmaceutical Manufacturing Hospitals 98

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. So, when could the goal of a net zero pharmaceutical industry be achieved?

Compounding 97

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97